Connect with us

Artificial Intelligence

WISeKey, OISTE.ORG and the Trust Protocol Association to Help Health Organizations Deploy a Covid-19 Trusted Health Passport on the Blockchain

GlobeNewswire

Published

on

WISeKey, OISTE.ORG and the Trust Protocol Association to Help Health Organizations Deploy a Covid-19 Trusted Health Passport on the BlockchainThe project is under the supervision of a new association, the Trust Protocol Association, established last January as an independent, not-for-profit membership organization, headquartered in Geneva, SwitzerlandGeneva, Switzerland – May 22, 2020 – The purpose of the Trust Protocol Association is to establish a new Trust Protocol for the Internet combining traditional Cryptographic Trust Models with distributed blockchain ledgers creating a new Global Trust platform.The mission of the Association is to create an ecosystem of governmental, technology and business partners, each representing a node with the possibility to have multiple nodes per country.Blockchain-based solutions aim to override the need for a central authority by distributing information previously held in a centralized repository across a network of participating nodes. While Blockchain is not owned by one individual or organization, anyone with an internet connection (and access, in the case of private Blockchains) can make use of it, help maintain and verify it. When a transaction is made on a Blockchain, it is added to a group of transactions, known as ‘blocks”. Each block of transactions is added to the database in a chronological, immutable chain. Each block is stamped with a unique cryptographic code, which ensures that records are not counterfeited or changed. The Blockchain approach lacks legal validity in most jurisdictions, which only recognize the digital signatures as equally valid that manuscript signatures when generated using traditional PKI technology.The Trust Protocol Association is working with a number of members in USA, Asia MEA and Europe to deploy a fully compliant Trusted Health Passport using the WIShelter Version 2, a new application in the WISeID App ecosystem, designed to remediate risks during the global COVID-19 lockdown period. Using their digital identity secured by WISeKey, users will be able to geo-localize other certified users and stablish secure communications. If needed, the app allows users to prove to local authorities that they are respecting the stay at home recommendations. To ensure the data privacy, each user’s Personal Identifiable Information is kept encrypted and never disclosed without their consent.
WIShelter app is based on WISeID, WISekey’s Digital Identity platform and combines in a unified solution a suite of web services and mobile applications:
The WISeID Account:  a digital identity with a unique credential that can be used to access all of WISeKey’s services and other affiliated servicesA Digital Certificate:  offers strong authentication and digital signatures which can be also used to protect users’ email and communication during TeleworkingA Personal Encrypted Vault: provides secure storage of confidential information, including the medical detailsThe new features of the WIShelter Version 2 include a full health digital certificate that is imported into the App by connecting it to the medical record of the patient issued by a bona fide qualified health certification program on which Doctors and Medical Facilities can join.
The App’s secure QR Code provides access to the user’s WISeID Health Card. The QR Code is displayed in three colors:
– Green: the person is healthy
– Yellow: the person’s health is compromised
– Red: the person has a health problem
The WISeID Health Card includes important medical details like blood type, allergies, and other medical conditions, and can be enriched with digital health certificates, as it’s the case of the result of an official COVID-19 test.
This simple method to display the Health Card could allow law enforcement and other public services to apply controls during the de-escalation phase of the pandemic.
All health details are encrypted and linked to the user’s identity, represented by a Digital Certificate. Encrypting this data is important to protect user’s confidential information and ensuring that the user is staying up-to-date with its health credentials, and is in compliance with all privacy requirements, like the European General Data Protection Regulation (Directive 95/46/EC), known as GDPR, the primary law regulating how companies protect EU citizens’ personal data.
WISeKey is a fully Qualified Trust Service Provider (TSP) under eIDAS, the updated EU regulations dealing with trusted eID and electronic transactions and Webtrust.ORG.
WISekey is currently working with several governments and health organizations to add functionalities to the WIShelter app such as the ability for users to upload and digitally certify the results of their COVID-19 test. These functionalities will allow local governments to enable healthy/immured persons to safely return to their jobs thus reduce the economic impact of the epidemic while protecting the high-risk population by controlling the spread of this infectious disease. 
For almost two decades, WISeKey has contributed to the design and implementation of global standards for the internet’s long-missing identity layer: decentralized, point-to-point exchange of information about people, organizations, or things – enabled by blockchain and certified by cryptographic Root of Trust. WISeKey’s technology, products and services can be used by individuals and organizations.
To that effect, WISekey has launched an enhanced version of WISeID, adding easy to use strong authentication and email security capabilities that can remediate threats like phishing, ransomware or identity theft. Strong Authentication is a mechanism able to enhance security by complementing the traditional username/password access to online services with additional security factors, like biometry, hardware tokens and one-time-passwords. Additionally, secure eMail techniques allow confidential messages to be exchanged encrypted, and to affix a “digital signature” to the outgoing email, ensuring the recipient that the message comes from a genuine person and that has not been manipulated in the way.About WISeKeyWISeKey (NASDAQ: WKEY; SIX Swiss Exchange: WIHN) is a leading global cybersecurity company currently deploying large scale digital identity ecosystems for people and objects using Blockchain, AI and IoT respecting the Human as the Fulcrum of the Internet. WISeKey microprocessors secure the pervasive computing shaping today’s Internet of Everything. WISeKey IoT has an install base of over 1.5 billion microchips in virtually all IoT sectors (connected cars, smart cities, drones, agricultural sensors, anti-counterfeiting, smart lighting, servers, computers, mobile phones, crypto tokens etc.).  WISeKey is uniquely positioned to be at the edge of IoT as our semiconductors produce a huge amount of Big Data that, when analyzed with Artificial Intelligence (AI), can help industrial applications to predict the failure of their equipment before it happens.
Our technology is Trusted by the OISTE/WISeKey’s Swiss based cryptographic Root of Trust (“RoT”) provides secure authentication and identification, in both physical and virtual environments, for the Internet of Things, Blockchain and Artificial Intelligence. The WISeKey RoT serves as a common trust anchor to ensure the integrity of online transactions among objects and between objects and people. For more information, visit www.wisekey.com.
About the Trust protocol Association
The purpose of the Trust Protocol Association (the Association) is to establish a new Trust Protocol for the Internet by combining traditional Cryptographic Trust Models with permissioned Blockchain transactions through strong authentication provided by the OISTE WISeKey Root of Trust, and create a new Global Trust platform and an ecosystem of governmental, technology and business partners, each representing a certification node with the possibility of having multiple certifications nodes per country. The Association promotes the use of Blockchain technologies internationally, facilitate the rapid adaptation and on-boarding of Blockchain-based solutions, foster stronger collaboration between the public, private and academic sectors.
https://trustprotocolassociation.org/About OISTE FOUNDATIONFounded in Switzerland in 1998, OISTE was created with the objectives of promoting the use and adoption of international standards to secure electronic transactions, expand the use of digital certification and ensure the interoperability of certification authorities’ e-transaction systems.
The OISTE Foundation is a not for profit organization based in Geneva, Switzerland, regulated by article 80 et seq. of the Swiss Civil Code. OISTE is an organization in special consultative status with the Economic and Social Council of the United Nations (ECOSOC) and belongs to the Not-for-Profit constituency (NPOC) of the ICANN. http://www.oiste.org/.
Mission: transfer the control and management of technologies dealing with digital identities to neutral authorities working for the public interest.Company Contact:
Dourgam Kummer 
Foundation Council Member
dourgam.kummer@oiste.org

Artificial Intelligence

Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology

GlobeNewswire

Published

on

CHICAGO, May 30, 2020 (GLOBE NEWSWIRE) — Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of offerings designed to both advance vital research and support physicians in treating cancer patients, despite the challenges of the COVID-19 pandemic. Tempus is equipping physicians with the tools they need to treat high-risk patients while limiting their exposure to the virus, with mobile phlebotomy services, on-demand virtual case reviews, and COVID-19 PCR diagnostic testing for cancer patients.
“Cancer continues to be among the leading causes of death worldwide, and now more than ever, it is critical that cancer patients continue to receive the care and treatment they need for survival despite the pandemic,” said Eric Lefkofsky, Founder and CEO. “In the last few months, we’ve quickly mobilized to create offerings that ease the burden on physicians treating cancer patients amidst the threat of COVID-19, through a series of services and tests that are badly needed to ensure therapies aren’t disrupted.”COVID-19 PCR Diagnostic Testing
Earlier this month, Tempus launched a diagnostic polymerase chain reaction (PCR) test for COVID-19. Tempus’ CAP-accredited/CLIA-certified labs in Chicago and Atlanta are supporting the acceleration of testing in the U.S., and expect to test approximately 12,000 patients daily across both labs, with the ability to scale further if needed. Tempus makes it seamless for physicians to test their patients for the virus, providing results within 24-48 hours at no cost to the patient as Tempus bills insurance directly.  
Mobile Phlebotomy
Tempus now offers mobile phlebotomy services, which are available to patients who require a blood draw but are too sick or unable to travel to the clinic, or do not have access to an in-office phlebotomist or draw site. Experts are able to perform blood draws in patients’ homes for any Tempus test in which a blood sample is required, at no added cost.
Virtual Case Reviews
Tempus’ on-demand virtual case review system provides clinical support to physicians and care teams in a timely manner when an in-person meeting isn’t possible. Tempus’ Medical Affairs team is available to answer patient report questions in real-time in a secure portal.   In addition, Tempus now offers a variety of tele-health support services specific to COVID-19 if needed.
Research Collaboration
Tempus has launched a large research collaboration to structure data for up to 50,000 COVID-19 positive patients.  As part of the IRB approved study, Tempus is partnering with providers to collect data on COVID-19 patients, which Tempus is structuring and de-identifying without cost.  In addition, Tempus expects to perform full transcriptomic profiling of approximately 10,000 patients within the cohort. All data will be shared with all participating institutions without restriction. 
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Erin Carron
communications@tempus.com

Continue Reading

Artificial Intelligence

Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones

GlobeNewswire

Published

on

CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) — Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a milestone in fully enrolling 2,500 oncologists into its Tempus Integrated Molecular Evaluation (TIME) Trial™ Program that seeks to rapidly match patients largely in the community setting to targeted clinical trials. To date, Tempus has signed up over 50 provider networks, over 30 unique biomarker trials, and has rapidly opened sites onto trials in an average of 10 days. Through the TIME Trial™ Program, Tempus is bringing the very best clinical trials to communities across the country, giving thousands of patients access to novel therapeutics.
“We have experience with clinical trial rapid deployment models, however Tempus provides an unparalleled level of commitment and support in aligning all involved parties and streamlining the process, especially given the challenges of the COVID-19 pandemic,” said Dr. Julio Peguero, Director of Research of Oncology Consultants. “We ultimately met our target goal of activating this trial in just two weeks, and hope to do the same for future patients.”Last spring, Tempus launched the TIME Trial™ Program in an effort to increase clinical trial participation by using real-time clinical and molecular data to match patients to trials, and then rapidly open pre-qualified sites once a patient has been identified. Since then, Tempus has built its TIME Trial™ Network, inclusive of some of the country’s top community hospitals and academic medical centers, totaling over 50 research sites and 2,500 oncologists.As of today, the program has 30 pharma-sponsored clinical trials, covering dozens of unique, actionable biomarkers across both solid and hematological malignancies. Every week, Tempus screens thousands of new patients against the criteria of the ultra-rare trials in the TIME Trial™ Network. Thus far, Tempus has matched nearly 1,000 patients to the trials in its portfolio and averaged just under 10 days from patient screened to site activated.“Cutting-edge cancer therapies increasingly target narrower populations of patients, and the clinical trials that study these therapies require equally specific patient populations,” said Amy Franzen, Vice President of Operations and Program Lead. “Tempus is able to use its advanced technology, access to real-time data, and strong operations to get the right patients access to the right therapies, closer to home.”Tempus screens patients from sites in the TIME Trial™ Network against applicable inclusion/exclusion criteria utilizing genomic sequencing data, matched with the patients’ clinical data. Then, Tempus applies its computational algorithm to provide rapid, comprehensive matches to applicable trials that can be brought to the patient. Once a patient has been screened and matched, Tempus provides the patient’s physician with a report that ranks relevant trials. If the physician expresses interest in enrolling his or her patient in a trial, the Site and Sponsor leverage a standard contract, standard rate card, and a central IRB to rapidly open the clinical trial and enroll the patient into the study in under two weeks.For the same reason that precision medicine is now possible due to technological advances such as cost effective genomic sequencing at scale, the maturing of artificial intelligence, and the evolution of cloud technology, it is now possible to run clinical trials more efficiently and based on real-time data. Tempus is increasing the speed of clinical trials and reaching into community settings, where the majority of cancer patients are treated today.About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Erin Carron
communications@tempus.com

Continue Reading

Artificial Intelligence

Completely Online Summer Math Camps Offered to Meet Strong Demand from Parents During COVID-19

GlobeNewswire

Published

on

San Diego, May 29, 2020 (GLOBE NEWSWIRE) — Parents looking for a summer camp this year may find that there are limited options due to COVID-19 social distancing guidelines. Art of Problem Solving (AoPS), a leader in math education that has prepared hundreds of thousands of students for some of the most prestigious universities, has transformed its Summer Camp activities online to create a collaborative learning and social space for children in third grade through high school. The Summer Camp activities help students develop problem solving skills through group activities in math and related subjects.Though this is the fourth year that Art of Problem Solving has offered a Summer Camp, this is the first time the organization is offering the camp experience completely online. Activities include learning how to develop cryptographic skills to protect internet security, to a class that integrates math learning as part of a poetry project that concludes with a Poetry Slam. The two-week and four-week sessions start in June and last through the summer.“As a result of the COVID-19 pandemic, many parents are seeking a summer camp experience for their children that conforms to social distancing norms while encouraging learning and collaboration,” said Richard Rusczyk, the founder of Art of Problem Solving, which has offered classes since 2003. “At Art of Problem Solving, we quickly adapted our on-campus Summer Camp experience with our online academic models. Our first-ever online Summer Camp is designed to encourage students to develop problem solving skills in a personalized and collaborative group environment.”The COVID-19 pandemic has created wider public awareness of the relevancy of math and statistics in everyday life. Rusczyk said his organization has seen that interest reflected in demand from more parents and children who see math skills as increasingly important. Also, in response to COVID-19, the company offered for a limited time a free trial to its Beast Academy program that integrates comic-style “beast” characters and exercises, puzzles and games.The Art of Problem Solving began in 1993 with a pair of textbooks for middle and high school math contest participants. Ten years later, Art of Problem Solving launched a website with an online school and full math curriculum designed for high-performing math learners. Every member of the 2015, 2016, 2018, and 2019 U.S. International Math Olympiad teams―each of which took first place in the competition―are Art of Problem Solving alumni who collectively participated in more than 110 Art of Problem Solving Online courses. The Art of Problem Solving is an ACS WASC Accredited School that offers programs online and, prior to COVID-19, at its nationwide campus locations. The organization also works with school districts to integrate their offerings as part of school math lessons.Looking beyond the immediate pandemic, problem solving skills are considered to be essential to the nation’s future workforce. As professions shift toward greater use of automation and artificial intelligence, there is expected to be an increased demand for people who have the ability to identify creative solutions and manage these developments. Critical thinking and problem solving is a top skill identified by National Association of Colleges and Employers.About Art of Problem SolvingArt of Problem Solving has successfully trained hundreds of thousands of motivated students in preparation for success at top-tier colleges and careers. Through rigorous, high-quality K-12 math curriculum, online classes and learning centers, Art of Problem Solving trains today’s brightest minds to solve tomorrow’s challenges. For additional information, visit www.artofproblemsolving.com.Jaclyn Walian
MIG
jwalian@migcom.com

Continue Reading

Trending

Roboticulized is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Roboticulized digests / hand picks the latest news about the AI industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Roboticulized.com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania